The team of AEvice Health with CEO Adrian Ang (second from right) and CTO Rex Tan (second from left). The team aims to begin clinical trials in 2020, and to launch the medical-grade device by 2022.
Caption: 
The team of AEvice Health with CEO Adrian Ang (second from right) and CTO Rex Tan (second from left). The team aims to begin clinical trials in 2020, and to launch the medical-grade device by 2022.